Imperial and GripAble have been awarded an £800,000 grant to help children with cerebral palsy in the clinic using a new arm strengthening device.
GripAble, a company formed by researchers from Imperial College London and clinicians from Imperial College Healthcare NHS Trust, is a digital assessment and training platform that supports people in rehabilitation for neurological and musculoskeletal disorders. skeletal. The company and Dr Firat Güder’s team at Imperial have been awarded the grant from the Biomedical Catalyst (BMC) Feasibility and Primer Awards 2021 competition, organized by Innovate UK.
My team and I are extremely excited to work with GripAble and other partners on this project, which will be a great learning opportunity for everyone involved. Dr. Firat Guder Department of Bioengineering
The funding will help bring an arm-strengthening device, named SqueezAble, to the clinic. The device combines new soft sensing technology and interactive play to revolutionize upper extremity therapy for children with cerebral palsy.
In the UK, an estimated 187,000 children live with arm disabilities and 85 million worldwide. Without regular occupational therapy for strength, dexterity and range of motion of the upper limbs and hands, a child’s condition is likely to deteriorate and impact their ability to live independently at home. ‘adulthood. Many arm disabilities are linked to neurological disorders such as cerebral palsy, which affects coordination, precision and timing of movements.
The project team will work with children with cerebral palsy to develop SqueezAble, having marketed its first hand-held, handheld therapy devices, the GripAble Pro and GripAble Home, for people with a variety of musculoskeletal and neurological conditions.
The project will incorporate user-centered design processes to develop and test SqueezAble with our target user group. Dr. Mike Mace Chief Technology Officer and Co-Founder, GripAble
Dr Güder, whose group in the Department of Bioengineering developed the underlying patent-pending soft sensor technology, said: “This project will enable us to build an entirely new medical device and concept to fill a large gap in current practice, which we hope will be particularly valuable for the rehabilitation of pediatric patients.
“My team and I are extremely excited to work with GripAble and other partners on this project, which will be a great learning opportunity for everyone involved.”
Working with an award-winning team of occupational therapists, clinical specialists and medical device engineers, the project aims to advance current prototypes into clinical translation.
Dr. Mike Mace, Chief Technology Officer and Co-Founder of GripAble, said: “Children living with arm disabilities need to learn to independently perform the bimanual activities of daily living, which requires them to use both hands. simultaneously to accomplish daily tasks like eating, writing, and washing.
“The project will incorporate user-centric design processes to develop and test SqueezAble with our target user group. In addition to developing the new SqueezAble technology, over the next two years we plan to create new two-handed games for functional movement training on the GripAble software platform, extending our current one-handed games.
This story was adapted from a GripAble press release.